Clincial Study of Fluticasone Propionate/ Salmeerol and Fluticasone Propionate in the treatment of Asthma patients. - Trial 2015-004883-12
Access comprehensive clinical trial information for 2015-004883-12 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Research & Development Ltd and is currently status unknown. The study focuses on Asthma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2015-004883-12
Trial Details
EU Clinical Trials Register • 2015-004883-12
Clincial Study of Fluticasone Propionate/ Salmeerol and Fluticasone Propionate in the treatment of Asthma patients.
Study Focus
Sponsor & Location
GlaxoSmithKline Research & Development Ltd
GlaxoSmithKline
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Mean change from baseline in pre-dose FEV1 over Weeks 1-52
ICD-10 Classifications
Asthma
Asthma, unspecified
Nonallergic asthma
Mixed asthma
Predominantly allergic asthma
Data Source
EU Clinical Trials Register
2015-004883-12
Non-Device Trial